would be $50+
cheap !!!!!!!! Loaded Up !!!!!!!
March 1, 2016
H.C. Wainwright Starts Celldex Therapeutics (CLDX) at Buy
H.C. Wainwright initiated coverage on Celldex Therapeutics (NASDAQ: CLDX) with a Buy rating and a price target of $25.
--all in baby --
grabbed a bunch
The Street says same thing, big win here.
Sentiment: Strong Buy
JP Morgan Spoke To CEO, CEO Says key growth drivers remain intact LINK
JPMorgan’s Top 4 Oversold Pharma Stocks for Patient Investors
By Laurie Kulikowski
Im in and holding- oversold
Marijuana’s Economic Impact Could Hit $44 Billion by 2020
Sarah Begley @SCBegley
March 15, 2016